Atlas Trials

Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF)

Clinical trial NCT02677701 · COMPLETED

Trial details

NCT number
NCT02677701
Sponsor
Seattle Children's Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2016-10-21
Primary completion
2020-02-13
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.